Cargando…
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Autores principales: | Montagne, Axel, Nation, Daniel A., Sagare, Abhay P., Barisano, Giuseppe, Sweeney, Melanie D., Chakhoyan, Ararat, Pachicano, Maricarmen, Joe, Elizabeth, Nelson, Amy R., D’Orazio, Lina M., Buennagel, David P., Harrington, Michael G., Benzinger, Tammie L. S., Fagan, Anne M., Ringman, John M., Schneider, Lon S., Morris, John C., Reiman, Eric M., Caselli, Richard J., Chui, Helena C., TCW, Julia, Chen, Yining, Pa, Judy, Conti, Peter S., Law, Meng, Toga, Arthur W., Zlokovic, Berislav V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250000/ https://www.ncbi.nlm.nih.gov/pubmed/32376954 http://dx.doi.org/10.1038/s41586-020-2247-3 |
Ejemplares similares
-
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
por: Nation, Daniel A., et al.
Publicado: (2019) -
Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults
por: Contreras, Joey Annette, et al.
Publicado: (2023) -
Functional connectivity among brain regions affected in Alzheimer’s disease is associated with CSF TNF-α in APOE4 carriers
por: Contreras, Joey Annette, et al.
Publicado: (2019) -
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
por: Arellanes, Isabella C., et al.
Publicado: (2020) -
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)